fludara
Showing 1 - 6 of 6
Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)
Recruiting
- Liver Cell Carcinoma
- +7 more
- CATCH T cells
- +2 more
-
Houston, TexasHouston Methodist Hospital
Dec 19, 2022
Neuroblastoma Trial in Houston (iC9-GD2 T Cells - frozen, iC9-GD2 T Cells - fresh, Cytoxan)
Active, not recruiting
- Neuroblastoma
- iC9-GD2 T Cells - frozen
- +5 more
-
Houston, Texas
- +1 more
Jan 4, 2023
Liver Cancer, Rhabdomyosarcoma, Malignant Rhabdoid Tumor Trial in Houston (CARE T cells, Cytoxan, Fludara)
Not yet recruiting
- Liver Cancer
- +5 more
- CARE T cells
- +2 more
-
Houston, TexasTexas Children's Hospital
Dec 1, 2021
Cancer Trial in Copenhagen (Autologous tumor-infiltrating lymphocytes, Ipilimumab, Nivolumab)
Unknown status
- Cancer
- Autologous tumor-infiltrating lymphocytes
- +5 more
-
Copenhagen, DenmarkCenter for Cancer immune Therapy (CCIT), Dept. of Hematology and
Aug 10, 2020
Relapse/Refractory Multiple Myeloma Trial in Belgium, United States (CYAD-211, Endoxan, Fludara)
Recruiting
- Relapse/Refractory Multiple Myeloma
- CYAD-211
- +2 more
-
Tampa, Florida
- +4 more
Nov 26, 2020
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Belgium, United States (CYAD-02, ENDOXAN, Fludara)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- CYAD-02
- +2 more
-
Jacksonville, Florida
- +4 more
Jun 8, 2020